Anterix Inc.
ATEX
$36.55
-$0.65-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.57M | 1.55M | 1.42M | 1.39M | 1.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.57M | 1.55M | 1.42M | 1.39M | 1.57M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.57M | 1.55M | 1.42M | 1.39M | 1.57M |
| SG&A Expenses | 10.10M | 9.85M | 11.94M | 10.81M | 10.51M |
| Depreciation & Amortization | 104.00K | 133.00K | 124.00K | 76.00K | 142.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.30M | 11.19M | 13.19M | 11.98M | 11.77M |
| Operating Income | -9.73M | -9.64M | -11.77M | -10.59M | -10.21M |
| Income Before Tax | -8.65M | 61.05M | 22.92M | 9.88M | 7.48M |
| Income Tax Expenses | -2.05M | 7.52M | -2.26M | 674.00K | -234.00K |
| Earnings from Continuing Operations | -6.60M | 53.54M | 25.18M | 9.21M | 7.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.60M | 53.54M | 25.18M | 9.21M | 7.71M |
| EBIT | -9.73M | -9.64M | -11.77M | -10.59M | -10.21M |
| EBITDA | -9.63M | -9.51M | -11.64M | -10.51M | -10.07M |
| EPS Basic | -0.35 | 2.86 | 1.35 | 0.50 | 0.41 |
| Normalized Basic EPS | -0.31 | -0.31 | -0.38 | -0.34 | -0.33 |
| EPS Diluted | -0.35 | 2.86 | 1.35 | 0.49 | 0.41 |
| Normalized Diluted EPS | -0.31 | -0.31 | -0.38 | -0.34 | -0.32 |
| Average Basic Shares Outstanding | 18.68M | 18.69M | 18.62M | 18.58M | 18.61M |
| Average Diluted Shares Outstanding | 18.68M | 18.71M | 18.70M | 18.71M | 18.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |